Barclays downgraded Certara (CERT) to Equal Weight from Overweight with an unchanged price target of $8. The company’s need greater investment across more of the business to accelerate core growth, the analyst tells investors in a research note. Barclays believes the market is showing little valuation support for Certara’s type of business.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara downgraded to Equal Weight from Overweight at Barclays
- Certara announces Simcyp Simulator predictions accepted by U.S. FDA
- Certara Earnings Call: Software Strength Amid Transition
- Craig-Hallum downgrades Certara to Hold following ‘mediocre quarter’
- Certara price target lowered to $10 from $12 at KeyBanc